Search all trials

Find therapies in clinical trials near you – page 47

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:(Phosphonooxy)Methyln-[(S)-[1-(Bicyclo[1.1.1]Pentan1-Yl)-1H-1,2,3-Triazol-4-Yl](2-Methyl-1-Oxo-1,2-Dihydroisoquinolin-5-Yl)Methyl]-N-{8-Chloro-3-Cyano-4-[(2,2-Dimethylpropyl)Amino]Quinolin-6-Yl]Carbamate

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma

Registered drug

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Dry eye+1

Not recruiting

Registered drug

Study on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

IgA nephropathy

Not recruiting

Registered drug

Study on the Effectiveness and Safety of RO7434656 for Patients with Primary IgA Nephropathy at High Risk of Progression

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Isis 696844

Contact Research Centre

Leiomyosarcoma metastatic

Not recruiting

Registered drugNo placebo

Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Filgrastim

Contact Research Centre

Essential thrombocythaemia+1

Not recruiting

Registered drugNo placebo

Study on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ropeginterferon Alfa-2B

Contact Research Centre

Acute myocardial infarction

Not recruiting

Registered drug

Study to Test BI 765845 for Patients with Heart Attack

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Bi 765845

Contact Research Centre

Macular oedema+1

Not recruiting

Registered drugNo placebo

Study on Ranibizumab Injections and Laser Treatment for Macular Edema in Central Retinal Vein Occlusion Patients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ranibizumab

Contact Research Centre

Pancreatic carcinoma+3

Not recruiting

InvestigationalNo placebo

Study on BI 907828 for Patients with Advanced Biliary Tract, Pancreatic, Lung, or Bladder Cancer

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:(3S,3'S,3A's,10A's)-6-Chloro-3'-(3-Chloro-2-Fluorophenyl)-1'-(Cyclopropylmethyl)-6'-Methyl-2-Oxo-1,2,3',3A',10',10A'-Hexahydro-1'H-Spiro[Indole-3,2'-Pyrrolo[2',3':4,5]Pyrrolo[1,2-B]Indazole]-7'-Carboxylic Acid

Contact Research Centre

HIV infection

Not recruiting

Registered drugNo placebo

Study Comparing Integrase Inhibitor (Bictegravir) and Boosted Protease Inhibitor (Darunavir) Treatments for Patients with Advanced HIV Infection

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bictegravir

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Doxorubicin

Contact Research Centre

HIV infection

Not recruiting

Registered drugNo placebo

Study on Switching HIV Treatment to Dolutegravir/Lamivudine in Patients Aged 50+ with Virologic Suppression

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bictegravir

Contact Research Centre

Find therapies in clinical trials near you – page 47

637 trials match your criteria

Colitis ulcerative

Study on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis

Malignant melanoma

Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma

Dry eye+1

Study on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome

IgA nephropathy

Study on the Effectiveness and Safety of RO7434656 for Patients with Primary IgA Nephropathy at High Risk of Progression

Leiomyosarcoma metastatic

Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma

Essential thrombocythaemia+1

Study on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments

Acute myocardial infarction

Study to Test BI 765845 for Patients with Heart Attack

Macular oedema+1

Study on Ranibizumab Injections and Laser Treatment for Macular Edema in Central Retinal Vein Occlusion Patients

Pancreatic carcinoma+3

Study on BI 907828 for Patients with Advanced Biliary Tract, Pancreatic, Lung, or Bladder Cancer

HIV infection

Study Comparing Integrase Inhibitor (Bictegravir) and Boosted Protease Inhibitor (Darunavir) Treatments for Patients with Advanced HIV Infection

Hormone receptor positive HER2 negative breast cancer

Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

HIV infection

Study on Switching HIV Treatment to Dolutegravir/Lamivudine in Patients Aged 50+ with Virologic Suppression

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.